dc.contributor.author |
Senadheera, G.P.S.G. |
|
dc.contributor.author |
Sri Ranganathan, S. |
|
dc.contributor.author |
Fernando, G.H. |
|
dc.contributor.author |
Fernandopulle, B.M.R. |
|
dc.date.accessioned |
2017-10-30T11:21:29Z |
|
dc.date.available |
2017-10-30T11:21:29Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
Senadheera, G.P.S.G., Sri Ranganathan, S., Fernando, G.H., Fernandopulle, B.M.R. (2016). "Outpatient quinolone consumption in Colombo", Proceedings of Inaugural Academic Sessions 2016, Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT), p. 27 |
en_US, si_LK |
dc.identifier.uri |
http://dr.lib.sjp.ac.lk/handle/123456789/6279 |
|
dc.description.abstract |
Attached |
en_US, si_LK |
dc.description.abstract |
Introduction and objectives: Overuse and irrational use of quinolones are key drivers of resistance. It is
quoted that for "Every 1% increase in ciprofloxacin use, there would be an immediate increase of 1.3% in the
number of community-acquired ciprofloxacin-resistant isolates and an additional 0.97% one month later".
Fluoroquinolone resistance and extended spectrum beta-lactamase-production in Enterobacteriaceae, is
known to be high in Southeast Asia. Furthermore resistance to fluoroquinolones escalates the threat of
treatment failure and death in patients with Multidrug Resistance tuberculosis. It is therefore important to
understand the true nature of their use. No such data is available in Sri Lanka. Objective of this study was to
describe the utilization pattern of quinolones in outpatient settings in Colombo district.
Method: From a large community based prescription survey carried out in a representative sample of public
sector and private hospital outpatient departments, retail and Rajya Osusala pharmacies(ROS) in Colombo
district for a period of one year in 2012-2013, details of prescriptions containing an oral quinolone were
extracted and analysed as per WHO methodology for community based surveillance studies. Utilization
volume of quinolones was quantified using Defined Daily Doses (DDD) and utilization pattern was analyzed in
terms of monthly trend, gender, age, setting and type of quinolone.
Results: Of the 22,279 prescriptions containing an antibacterial agent, 2824 (12.7%) had a quinolone
amounting to 16,324 DDDs. The volume was highest in ROS (34.5%) followed by private hospital OPD(29.9
%), retail(28.8%) and public hospital OPD pharmacies (6.8 %).Ciprofloxacin (47.4%) followed bylevofloxacin
(37.2%) accounted for about 84.6% of quinolones dispensed. Nalidixic acid was the least dispensed
quinolone throughout the year with an average of 12.4 DDDs/ month. Ofloxacin (2.7%) and moxifloxacin
(2.8%) utilization was low. A preponderance of males was observed in all except for nalidixic acid. Age wise it
is important to note that there were prescriptions for ciprofloxacin (11) and levofloxacin (3)in children
<4years although not recommended.
Conclusions: Utilization of quinolones for community acquired infection appears to be high in the Colombo
district demanding urgent remedial actions. Its use in public sector was less possibly due to restrictions
imposed on outpatient prescribing of quinolones.
Inaugural Academic Sessions S |
|
dc.language.iso |
en_US |
en_US, si_LK |
dc.publisher |
Proceedings of Inaugural Academic Sessions 2016, Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT) |
en_US, si_LK |
dc.title |
Outpatient quinolone consumption in Colombo |
en_US, si_LK |
dc.type |
Article |
en_US, si_LK |